BR0207829A - Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos - Google Patents

Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos

Info

Publication number
BR0207829A
BR0207829A BR0207829-5A BR0207829A BR0207829A BR 0207829 A BR0207829 A BR 0207829A BR 0207829 A BR0207829 A BR 0207829A BR 0207829 A BR0207829 A BR 0207829A
Authority
BR
Brazil
Prior art keywords
group
psychotic disorders
prevention
treatment
phenyl
Prior art date
Application number
BR0207829-5A
Other languages
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of BR0207829A publication Critical patent/BR0207829A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTOS DE CARBAMATO PARA USO NA PREVENçãO OU TRATAMENTO DE DISTúRBIOS PSICóTICOS". A presente invenção refere-se a um método para prevenir ou tratar distúrbios psicóticos compreendendo administrar a um indivíduo em necessidade deste uma quantidade terapeuticamente eficaz de um composto selecionado do grupo que consiste na Fórmula (I) e Fórmula (II): onde fenila é substituída em X com um a cinco átomos de halogênio selecionados do grupo que consiste em flúor, cloro, bromo e iodo; e, R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~ e R~ 6~ são independentemente selecionados do grupo que consiste em hidrogênio e C~ 1~-C~ 4~ alquila; onde C~ 1~-C~ 4~ alquila é opcionalmente substituída por fenila (onde fenila é opcionalmente substituída por substituintes independentemente selecionados do grupo que consiste em halogênio, C~ 1~-C~ 4~ alquila, C~ 1~-C~ 4~ alcóxi, amino, nitro e ciano).
BR0207829-5A 2001-02-27 2002-02-21 Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos BR0207829A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number Publication Date
BR0207829A true BR0207829A (pt) 2004-06-22

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207829-5A BR0207829A (pt) 2001-02-27 2002-02-21 Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos

Country Status (25)

Country Link
US (1) US6541513B2 (pt)
EP (1) EP1401424B1 (pt)
JP (1) JP4276841B2 (pt)
KR (1) KR100886578B1 (pt)
CN (1) CN1262271C (pt)
AR (1) AR032876A1 (pt)
AT (1) ATE346597T1 (pt)
AU (1) AU2002242296B2 (pt)
BR (1) BR0207829A (pt)
CA (1) CA2439480C (pt)
CZ (1) CZ302412B6 (pt)
DE (1) DE60216457T2 (pt)
DK (1) DK1401424T3 (pt)
ES (1) ES2275844T3 (pt)
HU (1) HUP0303342A3 (pt)
IL (2) IL157588A0 (pt)
MX (1) MXPA03007722A (pt)
NO (1) NO20033801L (pt)
NZ (1) NZ527991A (pt)
PL (1) PL365021A1 (pt)
PT (1) PT1401424E (pt)
RS (1) RS51056B (pt)
RU (1) RU2302240C2 (pt)
TW (1) TWI251486B (pt)
WO (1) WO2002067927A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2003445A3 (cs) * 2000-07-21 2004-08-18 Ortho@Mcneilápharmaceuticalźáinc Karbamátové sloučeniny pro prevenci nebo léčbu neuropatické bolesti a bolesti asociované s histaminovou a migrenózní bolestí hlavy
MXPA03007720A (es) * 2001-02-27 2004-11-12 Johnson & Johnson Compuestos de carbamato para su uso en la prevencion o el tratamiento de transtornos de ansiedad.
NZ527990A (en) * 2001-02-27 2006-01-27 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neurodegenerative disorders
RU2303445C2 (ru) 2001-07-16 2007-07-27 Орто-Макнейл Фармасьютикал, Инк. Карбаматные соединения для применения для предотвращения или лечения невропатической боли и боли, связанной с кластерной и мигреневой головной болью
WO2005107719A2 (en) * 2004-05-06 2005-11-17 Sandoz Ag Pharmaceutical composition comprising hydrophobic drug having improved solubility
AU2005335241B9 (en) * 2005-07-26 2012-12-20 Sk Biopharmaceuticals Co., Ltd. Methods for treating substance-related disorders
CN101568362A (zh) * 2006-10-30 2009-10-28 詹森药业有限公司 治疗抑郁症的方法
CN101568333A (zh) * 2006-10-31 2009-10-28 詹森药业有限公司 广泛性发育障碍的治疗
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
CN105164103B (zh) * 2013-03-12 2019-12-06 比皮艾思药物研发有限公司 苯基氨基甲酸酯化合物和含有其的预防或治疗记忆缺失相关疾病的组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
NZ527991A (en) 2005-04-29
TWI251486B (en) 2006-03-21
RU2302240C2 (ru) 2007-07-10
CZ20032297A3 (cs) 2004-06-16
RS51056B (sr) 2010-10-31
ES2275844T3 (es) 2007-06-16
CA2439480C (en) 2011-04-26
AR032876A1 (es) 2003-11-26
KR100886578B1 (ko) 2009-03-05
JP4276841B2 (ja) 2009-06-10
EP1401424B1 (en) 2006-11-29
US20020165272A1 (en) 2002-11-07
DE60216457D1 (de) 2007-01-11
IL157588A (en) 2009-12-24
EP1401424A1 (en) 2004-03-31
PT1401424E (pt) 2007-02-28
US6541513B2 (en) 2003-04-01
DK1401424T3 (da) 2007-02-26
NO20033801D0 (no) 2003-08-26
WO2002067927A1 (en) 2002-09-06
DE60216457T2 (de) 2007-09-20
CA2439480A1 (en) 2002-09-06
KR20030076713A (ko) 2003-09-26
MXPA03007722A (es) 2004-11-12
RU2003128983A (ru) 2005-03-10
PL365021A1 (en) 2004-12-27
HUP0303342A2 (hu) 2004-01-28
NO20033801L (no) 2003-10-22
ATE346597T1 (de) 2006-12-15
CN1262271C (zh) 2006-07-05
CN1505507A (zh) 2004-06-16
AU2002242296B2 (en) 2006-06-29
HUP0303342A3 (en) 2012-07-30
JP2004523556A (ja) 2004-08-05
RS67503A (en) 2006-12-15
CZ302412B6 (cs) 2011-05-04
IL157588A0 (en) 2004-03-28

Similar Documents

Publication Publication Date Title
BR0207645A (pt) Compostos carbamato para utilização na prevenção ou tratamento de distúrbios neurodegenerativos
BR0207831A (pt) Compostos carbamato para uso na prevenção ou tratamento de distúrbios do movimento
EA200800422A1 (ru) Способы лечения заболеваний, обусловленных химическими веществами
BR0207644A (pt) Compostos de carbamato para uso na prevenção ou no tratamento de distúrbio bipolar
BR0207673A (pt) Compostos de carbamato para o uso no tratamento de dor
BR0207832A (pt) Compostos de carbamato para uso na prevenção ou tratamento de distúrbio bipolar
BR0207829A (pt) Composto de carbamato para uso na prevenção ou tratamento de distúrbios psicóticos
EA200800295A1 (ru) Способы лечения эпилептогенеза
BR0207830A (pt) Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
BRPI0516112A (pt) métodos para neuroproteção
BR0112713A (pt) "compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada a cefaléia em cacho e hemicrânia
BR0211244A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada com cefaléia em salvas e enxaqueca
BR0211240A (pt) Compostos de carbamato para uso na prevenção ou tratamento de dor neuropática e dor associada à cefaléia em cacho e hemicrânia

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Free format text: JOHNSON & JOHNSON (US)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.